OncoImmunology (Dec 2023)

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues

  • Qikang Hu,
  • Meredith L. Frank,
  • Yang Gao,
  • Liyan Ji,
  • Muyun Peng,
  • Chen Chen,
  • Bin Wang,
  • Yan Hu,
  • Zeyu Wu,
  • Jina Li,
  • Lu Shu,
  • Qiongzhi He,
  • Yingqian Zhang,
  • Xuefeng Xia,
  • Jianjun Zhang,
  • Xin Yi,
  • Alexandre Reuben,
  • Fenglei Yu

DOI
https://doi.org/10.1080/2162402X.2023.2233399
Journal volume & issue
Vol. 12, no. 1

Abstract

Read online

ABSTRACTBackground A better understanding of T cells in lung cancer and their distribution across tumor-adjacent lungs and peripheral blood is needed to improve efficacy and minimize toxicity from immunotherapy to lung cancer patients.Methods Here, we performed CDR3β TCR sequencing of 136 samples from 20 patients with early-stage NSCLC including peripheral blood mononuclear cells, tumors, tumor edges (<1 cm from tumor), as well as adjacent lungs 1 cm, 2 cm, 5 cm, and 10 cm away from the tumor to gain insight into the spatial heterogeneity of T cells across the lungs in patients with NSCLC. PD-L1, CD4, and CD8 expression was assessed using immunohistochemical staining, and genomic features were derived by targeted sequencing of 1,021 cancer-related genes. Multiplex immunohistochemistry against PD-1, CTLA4, LAG3, and TIM3 was performed on four patients to assess T cell exhaustion.Results Our study reveals a decreasing gradient in TIL Tumor Infiltrating Lymphocytes homology with tumor edge, adjacent lungs, and peripheral blood but no discernible distance-associated patterns of T cell trafficking within the adjacent lung itself. Furthermore, we show a decrease in pathogen-specific TCRs in regions with high T cell clonality and PD-L1 expression.Conclusions Exclusion in T exhaustion cells at play across the lungs of patients with NSCLC may potentially be the mechanism for lung cancer occurrence.

Keywords